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Abstract
Background: Sudden limb paresis is a common problem in White Leghorn flocks, affecting about 1% of the
chicken population before achievement of sexual maturity. Previously, a similar clinical syndrome has been
reported as being caused by inflammatory demyelination of peripheral nerve fibres. Here, we investigated in detail
the immunopathology of this paretic syndrome and its possible resemblance to human neuropathies.
Methods: Neurologically affected chickens and control animals from one single flock underwent clinical and
neuropathological examination. Peripheral nervous system (PNS) alterations were characterised using standard
morphological techniques, including nerve fibre teasing and transmission electron microscopy. Infiltrating cells
were phenotyped immunohistologically and quantified by flow cytometry. The cytokine expression pattern was
assessed by quantitative real-time PCR (qRT-PCR). These investigations were accomplished by MHC genotyping and
a PCR screen for Marek’s disease virus (MDV).
Results: Spontaneous paresis of White Leghorns is caused by cell-mediated, inflammatory demyelination affecting
multiple cranial and spinal nerves and nerve roots with a proximodistal tapering. Clinical manifestation coincides
with the employment of humoral immune mechanisms, enrolling plasma cell recruitment, deposition of myelin-
bound IgG and antibody-dependent macrophageal myelin-stripping. Disease development was significantly linked
to a 539 bp microsatellite in MHC locus LEI0258. An aetiological role for MDV was excluded.
Conclusions: The paretic phase of avian inflammatory demyelinating polyradiculoneuritis immunobiologically
resembles the late-acute disease stages of human acute inflammatory demyelinating polyneuropathy, and is
characterised by a Th1-to-Th2 shift.
Background
With an incidence of about 1.5 per 100.000 citizen,
Guillain-Barré syndrome (GBS) is the most common
cause of acute flaccid paralysis in the western hemi-
sphere and probably worldwide [1]. Amongst different
GBS subtypes, acute inflammatory demyelinating poly-
neuropathy (AIDP) is the most prevalent form in Eur-
ope, North America and Australia. AIDP is
histopathologically characterised by the combination of
primary demyelination and infiltration by lymphocytes
and macrophages [2]. Chronic inflammatory demyelinat-
ing polyneuropathy (CIDP) is pathologically and epide-
miologically [3] similar to AIDP but it shows a
protracted or relapsing disease course [4], and is usually
responsive to immunosuppression by glucocorticoid
treatment [5].
Both GBS and CIDP are immune-mediated disorders
involving humoral and cellular effector mechanisms [2].
Thereby, both cascades appear to follow a stage-specific
sequence. After exposure to a causative environmental
(or endogenous) antigen, autoimmune mechanisms
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manner [6]. Even though, in clinical settings, the initial
trigger usually remains unknown, certain specific infec-
tions and vaccinations have been found to precede epi-
sodes of GBS, and it has been hypothesized that the
associated immunogens cross-react with epitopes of per-
ipheral myelin by means of a molecular mimicry
[2,5,7,8]. Recent studies have revealed that during the
plateau or recovery period of late stages of GBS there is
a shift from Th1 towards T-helper cell 2 (Th2)-guided
events, which suggests that the myelin-specific, Th2-
mediated humoral response might ameliorate the disease
course [9,10].
To date, most insights into the immunobiology of
inflammatory demyelinating neuropathies (IDP) have
been gained from experimental animal studies. The
most frequently employed model for GBS is experimen-
tal autoimmune neuritis (EAN) generated in Lewis rats.
These animals are immunized with peripheral myelin or
with the purified myelin proteins P0, P2 and/or PMP22.
Alternatively, EAN can be induced by adoptive transfer
of activated P2-specific neuritogenic T-lymphocytes
[11]. Various different EAN subtypes mirror the differ-
ent types and stages of natural IDP. Active EAN and
“adoptive-transfer EAN”, for example, reflect the Th1-
dominated stages of GBS [12,13] whereas immunisation
with a single large dose of PNS myelin or galactocereb-
rosides in complete Freund’s adjuvants lead to a chronic
progressive or relapsing disease course, compatible with
human CIDP [14]. None of the experimental models,
however, is appropriate in all regards as they may
include central nervous system (CNS) involvement,
which is not typical of natural IDP [12]. Moreover they
involve well-defined immunogenic triggers that are
more likely to be targets of secondary exposure than the
disease-causing immunogen in natural IDP.
Hence, a spontaneous animal model would be useful
to gain deeper insights into the complex immunological
aspects of disease development, if it were to prove
reproducible and broadly available for translational
research.
To date, spontaneous forms of CIDP have been
described in dogs and cats [15], but the apparently low
prevalence in these species precludes in-depth research.
Other types of polyradiculoneuritis, like coonhound
paralysis, are comparable to the axonal but not the
demyelinating form of the Guillain-Barré syndrome [15].
Being alerted by own observations and previous
reports on a sporadic paretic syndrome in up to 4% of
young White Leghorn layer chickens [16], we addressed
the question whether this disorder might resemble
mammalian IDP, and performed detailed investigations
on the disease phenotype, genetic background and expo-
sure to relevant infective agents.
We demonstrate here that the avian neuropathic dis-
ease bears striking similarities to late stage of human
AIDP. Even though the primary immunologic trigger
has not been identified, we identified an MHC-linked
g e n e t i cf a c t o r ,r e n d e r i n gt h ea n i m a l ss u s c e p t i b l et ot h i s
avian inflammatory demyelinating polyradiculoneuropa-
thy (AvIDP).
Methods
Animal selection
The present investigation enrolled 40 female White Leg-
horn chickens that originated from a commercial hybrid
flock comprising 5000 individuals. The chickens were
sorted into AvIDP-affected and disease-free individuals,
following neurological examination [17]. All animals
were euthanized using a lethal dose of intravenous
sodium pentobarbitone (2 ml/kg BM) [18].
Histopathology and transmission electron microscopy
Histotechnical processing
The cranial vaults and cranial nerve emergences were
carefully dissected and the brain and cranial nerve roots
were inspected in situ. Thereafter, the trigeminal and
oculomotor nerve roots were harvested for further
processing.
The brains were gently removed and immersed in 10%
neutral-buffered formalin for 48 hours. Fixed samples
were trimmed in transverse sections at the following
landmarks: (1) the caudal border of the olfactory bulbs,
(2) the optic chiasm, (3) the emergence of the oculomo-
tor nerve from the midbrain, (4) the cerebellar pedun-
cles, and (5) the obex.
The entire spinal cord was approached through lami-
nectomy. The spinal nerve roots and associated dorsal
root ganglia (DRG) were freed from overlying soft tissue
and inspected in situ. Samples of the spinal cord, nerve
roots and DRG of three consecutive segments of the
widest part of the cervical (C13, C14, Th1) and lumbo-
sacral (S5, S6, S7) intumescence were taken for further
investigations.
Morphological examination of the above mentioned
cranial and spinal nerves, the brachial plexus, sciatic
nerve and abdominal branch of vagus nerve included
paraffin and semithin histology, teased fibre evaluation
and transmission electron microscopy (TEM).
For routine histology, brain, spinal cord, DRG and
peripheral nerves underwent fixation in 10% neutral-
buffered formalin, processing in an automatic tissue pro-
cessor, embedding in paraffin (Paraplast®, Tyco Health-
care Group LP, Mannsfield, U.S.A.), sectioning at 5 μm
(PNS) and 8 μm (CNS), mounting on triethoxysilane-
coated slides (Sigma-Aldrich®, Steinheim, Germany) and
staining with haematoxylin & eosin (HE).
Further samples of spinal nerve roots and DRG as well
as the oculomotor nerve (CNIII), trigeminal nerve
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cut into 1- to 2-cm segments and immersed in 2.5% glu-
taraldehyde in 0.1 M Soerensen’s phosphate buffer (ph
7.4) for 1 hour. After fixation, the samples were rinsed
with Soerensen’s phosphate buffer containing 0.2 M buf-
fered D(+)-saccharose. The spinal nerves were cut into
10-mm pieces for nerve fibre teasing and blocks of 2
mm length were harvested from all nerve and DRG
probes for epoxy embedding.
Teasing samples were postfixed in 2% osmium tetrox-
ide for 1 hour and, after repeated buffer rinses, placed
into 100% water-free glycerol for 24 hours. After that, a
total number of 50 single-nerve fibres and/or small fibre
clusters were teased apart under a stereo magnifying
glass (Olympus SZH, Zeiss Stemi DV4, Germany).
Evidence of increased endoneurial round cells and
Schwann cell hyperplasia was further verified by toluidine
blue staining and subsequent teasing in aqueous medium.
The 2-mm pieces were postfixed in 1% osmium tetr-
oxide for 2 hours and underwent repeated buffer rinses
and a graded alcohol series before being embedded in
epoxy resin (Glycidether 100, Serva®, Heidelberg, Ger-
many). Semithin sections (0.5 μm) were mounted on
microscope slides and stained with azur II methylenblue
and safranin O.
Moreover, ultrathin sections (80 nm) were mounted
on copper rings covered by Formvar® foils (Plano, Wet-
zlar, Germany) and contrasted with lead-citrate and ura-
nyl-acetate.
Morphological examination
Light microscopical examination was performed on a
Zeiss Axiophot® (Zeiss Instruments, Oberkochen, Ger-
many) by two separate investigators (SB, KM) blinded
for the origin of these samples. HE-stained paraffin sec-
tions were inspected for interstitial and vascular changes
as well as for abnormalities affecting myelinated fibres
and fibre groups. The histological assessment was
accomplished using semithin sections that allowed a
deeper insight into single fibre pathology through better
preservation of the myelin substance, and served as
scout samples for subsequent electron microscopy. Eva-
luation criteria were in accordance to established proto-
cols for peripheral nerve examination [19]. Relevant
abnormalities were scored semiquantitatively into: 0
(absent), 1 (mild; < 25% of fibres in a fascicle cross sec-
tion affected), 2 (moderate; 25-50% of fibres affected), 3
(severe; >50% of fibres affected) as previously described
by Maier et al. [20]. In case of inter-rater discrepancy
t h es l i d e sw e r er e v i e w e da n dt h ef i n a lr e s u l t sw e r e
recorded after an agreement was achieved.
Nerve fibre teasing was performed to assess longitudi-
nal parameters and distribution patterns, to evaluate the
state of axons and myelin sheaths at different sub-seg-
mental levels, and to evaluate nodal gaps [21,22].
Ultrastructural analysis was performed and documen-
ted photographically with a Zeiss EM 10® (Germany) at
80 kV at magnifications from 2.500× to 80.000×.
Thereby, the myelin spirals could be evaluated in detail,
as well as the nerve fibre axoplasm and Schwann cell
perikarya [23]. Moreover, TEM analysis allowed the eva-
luation of unmyelinated fibre clusters [24].
Immune cell phenotyping
Immunohistochemistry (IHC)
Fresh samples of spinal nerve roots and DRG, oculomo-
tor nerve, brachial plexus and sciatic nerves were
embedded into OCT compound medium (TissueTek®;
Sakura Finetek, The Netherlands) prior to snap-freezing
in liquid nitrogen and storage at -80°C until further
processing.
Sections of 12 μm were performed using a cryostat
(Shandon Southern Products Ltd., Runcorn, Cheshire,
UK) and these were mounted on SuperFrost®Plus-slides
(Menzel-Gläser, Braunschweig, Germany).
Endogenous peroxidase activity was blocked by
i m m e r s i o ni n0 . 3 %h y d r o g e np e r o x i d ei nm e t h a n o lf o r
20 min before incubation with 10% normal goat serum
(1:20) for 30 min. Primary antibodies were directed
against: chB6 (AV20) (1:100) [25], CD3 (CT3) (1:5) [26],
CD4 (2-6) (1:2) [27], CD8 (3-298) (1:50) [28], TCRg/δ
(TCR1) (1:100) [29], TCRa/Vb1 (TCR2) (1:100) [30],
TCRa/Vb2 (TCR3) (1:100) [31,32], macrophage
(KUL01) (1:50) [33], MHCII (2G11) (1:500), IgG (G1)
(1:300) and IgM (M1) (1:500) [34]. All antibodies were
purified from cell culture supernatants. The antibodies
were applied to the slides overnight, at 4°C, followed by
a 30-min incubation with biotinylated secondary anti-
body (1:200; biotinylated goat-anti-mouse IgG, Vector
Laboratories, Burlingame, CA, USA). ABC Kit (Vectas-
tain®, Vector Laboratories, CA, USA; 30 min) and Histo-
Green (Linaris Biologische Produkte GmbH, Germany)
were used as detection kits. Sections were then counter-
stained with nuclear fast red, dehydrated and mounted
with Histofluid® (Marienfeld, Germany). The density of
respective immunopositive cells was assessed semiquan-
titatively using a modified protocol of Pavlakis et al.
[35]: mild (1+): < 2% of the cells positive; moderate (2
+): 2-10% of the cells positive; severe (3+): > 10% of the
cells positive. Localisation of the immune cells was eval-
uated in regard to infiltrated compartments and distri-
bution patterns.
Furthermore, the biotinylated lectin Ricinus communis
agglutinin-1 (RCA 120, 1:3000; Vector Laboratories, CA,
USA) was used as a specific marker for microglial cells
within the spinal cord [36]. Eight-micrometer-thick sec-
tions of paraffin-embedded samples of the spinal cord of
three consecutive segments of the widest part of the cer-
vical (C13, C14, Th1) and lumbosacral (S5, S6, S7) intu-
mescence were deparaffinised and hydrated through
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recommended by the manufacturer.
Flow cytometry
Spinal nerve roots and DRG from eight affected birds
were subjected to cell typing using flow cytometry.
Spinal nerve roots, including DRG, were cut into small
pieces with scalpel and tweezers. Tissue samples were
digested with collagenase type IV (Sigma, Poole, UK)
(0,05% in Hank’s balanced salt solution (HBSS) with Ca
2
+ and Mg
2+ and 5% FCS) in a shaking water bath at 37°
C for 30 min, followed by homogenisation with a 1-ml
syringe. After sedimentation of larger fragments on ice
for 10 min, the supernatant was transferred to a new
tube and cells were washed twice in PBS. Finally the
cells were resuspended in PBS with 1% BSA and 0.01%
NaN3.
Two-colour immunofluorescence staining of the cells
was performed according to standard procedures [37].
At first, cells were stained with a monoclonal antibody
(mAb) against CD45 combined with mAbs against chB6
(AV20) [25,38], IgM (M1) [34], CD4 (2-6) [27], CD8 (3-
298) [28], TCRg/δ (TCR1) [29], TCRa/Vb1 (TCR2) [30],
TCRa/Vb2 (TCR3) [31], MHCII (2G11) [39] and/or
macrophage (KUL01) [33], followed by staining with an
isotype-specific anti-mouse-IgG2a-FITC conjugate and
an anti-mouse-IgG1 or IgG2b-phycoerythrin (PE) -con-
jugate (Southern Biotechnology Associates, Birmingham,
Alabama, USA), respectively. Analysis was performed
with a FACScan (Becton Dickinson, Heidelberg, Ger-
many) and FlowJo software (Tree Star Inc, Oregon,
USA).
Fluoroscence microscopy
To demonstrate the spatial relationships between infil-
trating cells and nerve fibres, unfixed samples of the
sciatic nerve underwent whole-mount immunofluores-
cence investigations. The fascicles were grossly separated
from epi- and endoneurium and gently teased apart
under a stereo magnifying glass. They were mounted
with normal goat serum (1:20) for 30 min followed by
an incubation with rabbit anti-laminin antibody (1:200;
Abcam, Cambridge, UK) overnight, at 4°C, and with
fluorescein-5-isothiocyanat (FITC)-conjugated goat anti-
rabbit antiserum (1:400, 30 min; Sigma, Poole, UK),
thereafter. Finally, diamidino-2-phenylindol (1:50; DAPI
BioChemica, AppliChem GmbH, Darmstadt, Germany)
was applied on the sample for 30 min.
The nerve fibre bundles were then teased in aqueous
medium and examined with a scanning microscope
Zeiss LSM® 510 equipped with a Zeiss Axiovert 100 M®,
a 488 nm argon laser and a 770 nm biphotonic laser.
Settings were at 490 nm (track 1/FITC) and 365 nm
(track 2/DAPI) wave-length.
Additionally to IHC, cryosections of sciatic nerve and
spinal nerve roots, including DRG, were tested for
presence of IgM and IgG with immunofluorescence.
The slides were mounted with normal goat serum (1:20)
for 30 min followed by an incubation with the particular
primary antibody (mouse anti-IgM1 [1:500] or mouse
anti-IgG1 [1:300]) for 2 h at room temperature. There-
after, R-phycoerythrin (RPE)-conjugated goat anti-
mouse antiserum (1:400; Alexa Fluor, Eugene, Oregon,
USA) and, at last, DAPI (1:50) were applied to the sam-
ple for 30 min.
Examination took place using the scanning micro-
scope Zeiss LSM® 510 (see above) at wavelength settings
of 495 nm (track 1/RPE) and 365 nm (track 2/DAPI).
Quantitative real-time RT-PCR (qRT-PCR)
Pieces of spinal nerve roots, including DRG, were
extracted, immediately snap frozen in liquid nitrogen,
and stored at -80°C until further processing. For RNA
isolation, TRIzol™ Reagent® (Invitrogen, Karlsruhe, Ger-
many) was used according to the manufacturer’sp r o t o -
col. The quantity of extracted RNA was determined by
photometry, while the RNA quality was analysed using a
2100 Bioanalyzer® (Agilent Technologies, Böblingen,
Germany). Only RNA samples with an RNA integrity
number (RIN) exceeding 7.0 were used for qRT-PCR
analysis.
Genomic DNA elimination and reverse transcription
were performed using a QuantiTect Reverse Transcrip-
tion Kit® (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. The reverse transcription
reaction was carried out for 30 min at 42°C and termi-
nated by incubating the samples for 3 min at 95°C.
Primers for qRT-PCR (Table 1) were designed using
PrimerExpress software® (Applied Biosystems, Warring-
ton, UK) and were obtained from MWG-Biotech®
(Ebersberg, Germany).
Quantitative RT-PCR was performed using a 7300
Real-Time PCR System® (Applied Biosystems, Warring-
ton, UK) with SYBR-Green as a double-stranded DNA-
specific fluorescent dye. Amplification mixes contained
1 μL cDNA, 12.5 μL QuantiTect SYBR Green PCR Kit®
(Qiagen, Hilden, Germany), 1.5 μL forward and reverse
primer (final concentration 300 nM), and 8.5 μL water.
The detector system was programmed to start with an
activation step for 15 min at 95°C followed by PCR pro-
gram with 40 cycles of DNA denaturation (15 sec at 94°
C), primer annealing (30 sec at 59°C), and elongation
(30 sec at 72°C). Each qRT-PCR was run in triplicate.
Specificity of the resulting qRT-PCR products was veri-
fied by melting curve analysis.
To normalize the data, the cycle threshold (CT) values
of the housekeeping gene 18S rRNA were subtracted
from the target gene CT value of the sample (= dCT).
Genotyping
For MHC genotyping, commercial White Leghorn layer
hybrids were used, all originating from the same variety
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lected from clinically affected chickens at an age of six
weeks. Furthermore, a sampling from healthy animals
was performed. In total, samples from 152 healthy and
113 affected chickens were collected.
The microsatellite marker LEI0258 is known to be
located within the MHC, between the BG and BF
regions, and an association between LEI0258 alleles and
serologically defined MHC haplotype has been reported
[40]. The aim of the genotyping was to evaluate a possi-
ble association between MHC and the occurrence of the
paralytic syndrome as previously observed in peripheral
neuropathy [16].
A drop of blood was obtained from the wing vein of
each bird and absorbed onto Whatman FTA® filter cards
(Whatman International Ltd., Maidstone, UK), and
dried and stored in an aluminium foil envelope at room
temperature until analysis. DNA isolation was carried
out using the phenol-chloroform method [41].
PCR was performed using HotStarTaq Master Mix Kit
(Qiagen, Hilden, Germany) on an Eppendorf Mastercycler
using 20 ng DNA. To amplify locus LEI0258 the forward
primer sequence was 5’cacgcagcagaacttggtaagg 3’,w h i l e
the reverse primer sequence was 5’agctgtgctcagtcctcagtgc
3’. An initial denaturation was performed at 95°C for 15
min, followed by 35 cycles at 94°C for 1 min, 58°C for 1
min and 72°C for 1 min. The PCR finished with a final
extension at 72°C for 10 min. DNA fragments were ana-
lyzed by electrophoresis on a 4% agarose gel for 3 h at 6
V/cm, and visualized with ethidium bromide staining on
UV light. Resulting fragments corresponded to alleles of
261 bp, 357 bp, and 539 bp, respectively.
Statistical analyses
T h ed a t aw e r ea n a l y z e db yag e n e r a l i z e dl i n e a rm o d e l
using proc LOGISTIC (SAS Institute, 2008) with geno-
type and farm as main effect. An Exact Conditional Test
was performed for including variables in the model.
Only genotype remained as a significant variable in the
final model, using a significance level of p < 0.05. Odds
ratios and 95% confidence intervals were calculated for
different levels of significant main effects using the pair-
wise CONTRAST statement. Wald statistics were used
in determining the statistical significance of estimated
odds ratios. The raw frequencies of genotypes were
counted using Proc FREQ (SAS, SAS Institute, Heidel-
berg, Germany).
PCR analysis for MDV strain discrimination
Samples of spleen, sciatic nerve, and spinal nerve roots,
including DRG, were collected from 10 AvIDP-affected
and non-affected White Leghorn chickens, all of which
were vaccinated against Marek’s disease with avirulent
MDV-CVI988/Rispens (AviPro MD RISPENS RL, Loh-
mann Animal Health, Cuxhaven, Germany). Similarly,
organ samples were collected from 10 six-week-old spe-
cific-pathogen-free (SPF) control chickens (Lohmann
VALO SPF). Genomic DNA from 10 (spleen tissue) to
20 mg (nerve tissue) of each organ sample was isolated
using the QIAamp DNA Mini Kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’sp r o t o c o l .D N A
concentrations were measured using a NanoDrop spec-
trophotometer (NanoDrop Technologies, Wilmington,
Delaware, USA) and adjusted to a final concentration of
100 ng/μl. One hundred ng of DNA of each sample
were then analysed by conventional PCR (40 cycles of
30 sec at 94°C, 30 sec at 55°C, and 45 sec at 72°C) using
the Thermoprime Plus Mastermix (ABgene, Surrey, UK)
and the oligonucleotide primers given in Table 2. Pri-
mers UL49amp_fw and UL49amp_rv were designed to
amplify a region of 618 base pairs (bp) in the UL49-
ORF of MDV. Primers UL49disc_fw and UL49disc_rv
span a fragment of 320 bp located within the 618 bp
region and were conceived to discriminate CVI988/Ris-
p e n ss t r a i n sf r o mv i r u l e n tM D Vf i e l ds t r a i n st h r o u g ha
DNA polymorphism found in the UL49-ORF of
CVI988/Rispens [42]. Controls for the PCR analysis
included MDV-DNA isolated from the very virulent
Table 1 Primers used for RT-qPCR analysis.
Gene Forward Reverse
18S rRNA TGTCTAAGTACACACGGGCGGTACA GGCGCTCGTCGGCATGTATTA
CD3ε CATCGCTGCGGATCTTCTCA GCTGCATCTTCTGGGCTCGT
chB6 GATCGCCTGCCCTCCAAT TGGCTTTCCACGTCAGCTATC
Blimp-1 GTGGTATTGCCGAGACTTTGC GGGTTTGTGTGAGGTTCATCATT
AID CGTCTGAAACCCAGCAAGAGT TGTCCATGTCAGCTGGGTTCT
iNOS AAGCAAACGGCCAAGATCCA CCCACCTCAAGGAGCATGTTG
IFNg TGGCGTGAAGAAGGTGAAAGA TCTGAGACTGGCTCCTTTTCCT
IL-1 CTGAGTCATGCATCGTTTATGTTTC AAATACCTCCACCCCGACAAG
IL-6 GCTTCGACGAGGAGAAATGC GCCAGGTGCTTTGTGCTGTA
IL-10 CGGGAGCTGAGGGTGAAGT CAGCCAAAGGTCCCCTTAAAC
IL-13 GCCACAGTGCTGGACAACAT ATGCCGTGCAGGCTCTTC
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1-transformed lymphoblastoid cell lines 54-O [Trapp et
al., unpublished data] and MSB-1 [43], as well as
CVI988/Rispens-DNA isolated from two different com-
mercially available vaccine preparations (AviPro MD
RISPENS RL, Lohmann Animal Health, Cuxhaven, Ger-
many, and Nobilis Rismavac, Intervet International
GmBH, Unterschleissheim Germany).
Results
Clinical presentation
The 20 affected animals revealed histories of impaired
limb movements with an onset prior to achievement of
sexual maturity at an age between 5 and 13 weeks. All
affected animals uniformly showed a progressive asym-
metric paresis of one or multiple extremities on neuro-
logical examination. Wing and leg involvement was
characterized by weakness progressing to flaccid paresis.
In the due course of the disease the proximal limbs
show intermittent relative extensor hypertonicity. In
addition, limb weakness was accompanied by fascicula-
tions of limb and neck musculature. Postural reactions
in the affected legs were absent or markedly decreased.
The 20 age-matched control chickens behaved nor-
mally during open-field observation and did not exhibit
any dysfunctions on clinical and neurological
examination.
Morphological findings
On necropsy, all clinically ill chickens revealed a severe,
bilaterally symmetrical oedematous thickening of the
cranial and spinal nerve roots. Amongst cranial nerves,
the maxillary and ophthalmic branches of CN V were
most severely affected (Figure 1A and 1B). To a slightly
lesser degree, the oculomotor (CN III) and facial nerve
(CN VII) were involved.
In affected chickens, the spinal nerve roots emerging
from the cervical and lumbosacral intumescences
showed identical changes. Their diameters measured up
to four times the normal calibre (Figure 1C and 1D).
Thereby, the diameters tapered off centrifugally so that
the nerves presented normal diameters immediately dis-
tal to the intervertebral foramen.
Microscopically, all examined parts of the peripheral
nervous system of ill animals showed concurrent
inflammation and demyelination. Thereby, the former
was characterised by multifocal lymphohistiocytic infil-
trates, with some perivascular cuffing - particularly fre-
quent and most severe in the ganglia - and scattered
plasma cells throughout the endoneurium of the nerves
and ganglia. Inflammation seemed to start directly at
the CNS-PNS transition, without involving the central
neuroparenchyma (Figure 2, 3, 4 and 5), culminated in
the roots, and tapered off from proximal to distal (Fig-
ure 2, 3 and 4). Hence, the prevertebral and cranial
nerve ganglia were amongst the hot spots. Both dorsal
and ventral roots revealed similar inflammation scores.
Clinically healthy chickens sometimes revealed follicular
lymphocytic infiltrates within the dorsal ganglia consis-
tent with findings of other groups [16,44,45].
In affected chickens, at most 50% of the cross sec-
tional area of CNs III and V, the brachial plexus, and
the sciatic nerve were pathologically altered, especially
in the most proximal parts. Only the vagus nerve was
lacking length-dependent features and presented with a
diffuse inflammation of the entire endoneurium in all
samples. Notably, the infiltration foci colocalised with
large clusters of nude and hypomyelinated axons.
Teased preparations of affected nerves revealed a multi-
segmental and, infrequently, also paranodal cell-
mediated demyelination involving numerous mononuc-
lear cells with macrophage characteristics that pene-
trated the Schwann cell basal lamina at the Schmidt-
Lanterman incisures. Consistent with ongoing remyeli-
nation, inappropriately thin myelinated fibres were
recognised in many areas. These remyelinating segments
and many demyelinated axons were encircled by super-
numerary Schwann cell processes.
Myelin sheath alterations were accompanied by a sig-
nificant expansion of the collagenous inner endoneurial
sheath (Figure 6). This increase of extracellular matrix
compensated for the decreased nerve fibre diameters
following myelin loss.
Transmission electron microscopy of the affected per-
ipheral nerves basically confirmed the light microscopic
features. Macrophages multifocally were invading the
myelin spiral at the outer mesaxon (Figure 7). Schwann
cell nuclei and perikarya showed no signs of degenera-
tion (Figure 8). Apart from a very mild decrease of dia-
meter and slightly more densely packed neurofilaments,
the axons retained their normal ultrastructural architec-
ture throughout all affected areas.
Similar findings were not recognised in age-matched
control animals.
Immunostaining
IHC revealed a similar inflammatory cell composition in
the samples of spinal nerve roots and associated DRG,
CN III, brachial plexus and sciatic nerves. IgM-positive
Table 2 Oligonucleotide primers used for Marek’s disease
virus PCR analysis
UL49amp_fw 5’-ATGGCGACGCGAAGTTG-3’
UL49amp_rv 5’-CCATCAACACGTACTCAGCGA-3’
UL49disc_fw 5’-CTTGTACGTTCAGATTTGGTTG-3’
UL49disc_rv 5’-TCATCAGCATCTAGCACTTGG-3’
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Page 6 of 20Figure 1 Gross findings in AvIDP-affected chickens. Compared to controls (A, C) a marked thickening of craniospinal nerve roots was
recognized in all affected birds (B, D). A, B: Inspection of the ventral brain surface reveals severely enlarged maxillary (CN Vmax) and ophthalmic
(CN Vopht) nerve branches. The oculomotor (CN III) and abducens (CN VI) nerve are also thickened to a lesser extend, and show a mild greyish
discoloration. C, D: The dorsal view at the cervical intumescence between C13 and Th1 indicates severe enlargement of the dorsal rootlets
(arrows) and the associated dorsal root ganglia (DRG). Affected ganglia (b) measure up to fourfold the diameters of unaffected control nerves (a).
A, B: EB = eye ball; NO = optic nerve; P = Pons; scale bar = 1.0 cm. C, D: SC: spinal cord; scale bar 0.5 cm.
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Page 7 of 20plasma cells were diffusely scattered amongst the endo-
neurial compartment.
Furthermore, the affected nerves showed a moderate
multifocal infiltration of chB6-positive B-cells and a
severe multifocal infiltration of CD3-positive T-cells.
Overall, the extent of infiltration by the latter appeared
about twice as severe as the degree of B-cell
involvement.
Large perivascular clusters showed an intermingled
cell composition of mainly CD3- and chB6-positive cells
interspersed with a few KUL01-positive macrophages
(Figure 9). All control chickens displayed a few isolated
B-cells and T-cells per fascicular cross section surround-
ing venules, compatible with score of 1+ (data not
shown).
Empirically, the T-cell population in affected animals
consisted of equal fractions of T-helper cells (CD4
+) and
cytotoxic T-cells (CD8
+). Most of the T-cells carried ab
T-cell receptor, while a small minority stained positively
for TCR1 (gδ T-cells). These T-cell phenotypes inter-
mingled intensely and there was no spatial organisation.
In ill birds, KUL01-positive histiocytes and macro-
phages were seen frequently in the perineurium and
subperineurial spaces, and they intermingled with lym-
phocytes in large perivascular infiltrates. Compared to
control tissue, where we could find single positive cells
with the same distribution pattern, the overall density
was mildly to moderately increased. The distribution of
MHCII-expressing, antigen-presenting cells extended
over both macrophage populations and those areas
occupied by lymphocytes, showing a severe rise com-
pared to control animals.
Apart from cell-associated immunoglobulin staining,
patchy IgG-positive signals were confined to the myelin
sheaths of large myelinated fibres in spinal nerve roots,
including DRG, and peripheral nerve segments (Figure
10).
Flow cytometry identified large numbers of the iso-
lated cells from spinal nerve roots, including DRG, that
were CD45-positive leukocytes (Fig. 11A middle panel).
The composition of this leukocyte population basically
matched the IHC results. The lymphocyte population
consisted of 42% B-cells (AV20
+) and approximately
43% T-cells. The T-cell population split into cytotoxic
T-cells and T-helper cells at a ratio of 1:0.94 or, relating
to the T-cell receptor, at a ratio of 1:0.18 for ab T-cells
(TCR2 and TCR3) to gδ T-cells (TCR1; Fig. 11B).
About 4% of the isolated leukocytes were monocytes
and macrophages (KUL01
+)a n dam a j o r i t y-m o r et h a n
57% - of the cells carried MHC class II antigens.
Fluorescence microscopy
In addition to Schwann cells, further DAPI-stained
nuclei were detected under the laminin-stained basal
lamina of the inner endoneurial sheath. In agreement
with the results of the transmission electron microscopy,
they were considered to be invading macrophages. As in
the IHC samples, IF revealed positive signals for IgG on
the surface of myelin sheaths of multiple large myeli-
nated fibres in spinal nerve roots, including DRG, and
distal nerve segments.
Quantitative RT-PCR
Expression levels of characteristic T- and B-cell genes
were significantly increased in spinal ganglia of affected
birds in comparison with controls (Figure 12). Averaged
differences of 2 and 3.5 CT values (equivalent to a 9-
fold and 13-fold increase) were observed for CD3ε and
chB6 (a chicken B-cell antigen), respectively, thus con-
firming the histological and flow cytometric results. In
addition to chB6 expression as a marker for immature,
mature, and differentiating B-cells in germinal centres
(GC), the elevated expression of Blimp-1 and AID with
3 and 1 CTs difference between control and diseased
birds indicated that there was also a significant plasma
cell activation and induction of hypermutation and class
switching events in the analysed spinal ganglia and asso-
ciated nerve roots.
No differences were observed in the expression levels
of the inflammatory cytokines IL-1 and IL-6. Likewise,
inducible nitric oxide synthase (iNOS) expression as a
marker for activated macrophages showed no significant
difference between the two groups. The elevated error
bar in the control group originates from a single bird
with very low iNOS mRNA levels. Without this animal
Figure 2 CNS-PNS transition as the border of inflammation. The
arrows point to the CNS - PNS boundary of the spinal roots. Despite
the severe involvement of both dorsal (DR) and ventral (VR) nerve
roots, the inflammatory infiltration spares the adjacent central white
matter and does not pass the PNS-CNS transition. Scale bar = 0.5
mm.
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iNOS in affected and control organs.
Further analysis of cytokine gene expression revealed a
significant induction of IFN-g mRNA in diseased organs
(3 CT values corresponding to a 7-fold increases) while
the Th2 cytokine IL13 was unchanged. The regulatory
cytokine IL-10 was significantly upregulated in ganglia of
affected birds (3 CT values, corresponding to 7-fold
increase).
Genotyping
The three alleles at locus LEI0258 found in the chicken
flock under study corresponded to allele sizes of 261 bp,
357 bp, and 539 bp, respectively (Figure 13). According to
this the following genotypes were observed: Genotype
[261/261]; Genotype [261/539]; Genotype [357/539]; Gen-
otype [261/357]. The frequency of these different geno-
types in association with healthy and clinically diseased
animals is presented in Table 3. Genotypes [261/539] and
[261/357] occurred in significantly higher numbers of
observation (150, 85) than genotypes [261/261] and [357/
539] (18, 12). There was a marked difference between the
genotypes in the occurrence of AvIDP symptoms. While
the percentage of sick animals was 16.7% and 9.4% in gen-
otypes [261/261] and [261/357], this proportion was signif-
icantly higher in genotypes [261/539] and [357/539], with
frequencies of 64.7% and 41.7%, respectively.
Figure 3 CNS-PNS transition at the dorsal nerve root as the border of inflammation. On closer inspection, the dorsal root (DR) of an
affected animal (B) shows a mononuclear infiltration in comparison to a control chicken (A). The arrows point to the CNS - PNS boundary. Note
that the adjacent white (WM) and grey matters (GM) are not affected. Scale bar = 1 mm.
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nificant effect (p < 0.001) of explanatory variables. The
factor ‘Genotype’ is the only one that can be signifi-
cantly substantiated (p < 0.0001).
Animals of the [261/539] genotype had a 9.15-fold
higher risk of AvIDP compared to genotype [261/261]
(CI 2.50-33.04). Compared to genotype [261/357],t h e
risk of showing AvIDP symptoms was even higher for
genotype [261/539] (17.6-fold, CI 7.9-39.7). Further-
more, the likelihood of genotype [357/539] to be
affected by AvIDP was higher than those of genotype
[261/357] by a factor of 6.8. There were neither signifi-
cant difference between animals of the genotype [357/
539] and [261/539], nor between animals of the geno-
types [261/357] and [261/261] (Table 4).
PCR analysis for MDV strain discrimination
PCR analysis of the various organ samples revealed all
spleens and some nerve tissues of the vaccinated chick-
ens to be positive for MDV-DNA. However, none of the
organ samples scored positive for MDV field strain-
DNA in the discriminating PCR. As a proof of principle,
all viral DNAs used as controls scored positive for
MDV-UL49, but only those from the non-vaccine virus
strains RB-1B and BC-1 allowed specific binding of the
discrimination primer (UL49disc_fw) and amplification
of detectable PCR-products.
Figure 4 CNS-PNS transition at the ventral nerve root as the border of inflammation. The ventral nerve root (VR) of an affected animal (B)
presents with a severe mononuclear infiltration and thickening in comparison to a control chicken (A). The arrows point to the CNS - PNS
boundary. Again, the inflammatory infiltration spares the adjacent central white (WM) and grey matters (GM) and does not pass the PNS-CNS
transition. Scale bar = 1 mm.
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During the last decade, an acute paretic syndrome of
unclear origin was increasingly reported from flocks of
White Leghorn chickens worldwide [16]. In an effort to
elucidate the underlying cause and pathobiology of this
syndrome we performed an extensive pathohistological
and immunological investigation.
All birds of our collective that presented with limb
paresis showed severe demyelination of peripheral
nerves, with a predilection for craniospinal nerve roots
and associated ganglia. This demyelination was asso-
ciated with multifocal endoneurial infiltration by lym-
phocytes, plasma cells and macrophages. TEM
provided evidence of macrophages invading myelin
spirals at the outer mesaxon, between the paranodal
loops and Schmidt-Lanterman incisures, leading to
stripping off of myelin lamellae from morphologically
intact axons. This picture closely resembles human
AIDP, which leads us to denote this disease as avian
inflammatory demyelinating polyradiculoneuritis
(AvIDP) [46,47].
Several pathways have been proposed by which the
attention of macrophages is directed towards the myelin
sheath. Firstly, autoreactive T-helper cells may secret
chemokines attracting macrophages to the endoneurium
and, subsequently, activate them via macrophage-
Figure 5 Immunohistochemical illustration of Ricinus communis agglutinin-1 (RCA-1) -positive microglial cells in the white matter of
spinal cord. The RCA-1-positive microglial cells (arrowheads) in both healthy (A) and AvIDP-affected (B) chicken show incospicuous ramified
microglial cells. Activated microglial cells or an increased number were not observed. A, B: asterisk = endothelium (also stains RCA-1 positive);
scale bar = 250 μm.
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Page 11 of 20Figure 6 AvIDP: typical histological PNS findings. The histological appearance of a healthy mixed fascicular nerve is displayed in figure A. Its
endoneurium (E) contains large (LMF) and small (SMF) myelinated fibres that are confined by a peripheral rim of blue (azurophilic) compacted
myelin. B: AvIDP leads to a breakdown of the myelin sheath while leaving the axons mainly untouched. Concomitantly with the myelin loss
(arrow), an expansion of the eosinophilic extracellular matrix of the endoneurial sheath develops which results in a decrease of nerve fibre
density. A, B: P = perineurium; scale bar = 100 μm.
Figure 7 Macrophage-mediated myelin stripping. A: Upon invasion of the Schwann cell tubes, macrophage processes (arrows) split the outer
mesaxon in order to gain entry to the myelin spiral. B: They invade the myelin following the intraperiod line (arrow). Widening propagates
centripetally towards the inner mesaxon. B: MS = myelin sheath; Scale bar = 2 μm.
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Page 12 of 20activating factors. Activated macrophages also are cap-
able of recognising the Fc-region of auto-antibodies that
opsonise myelin epitopes and/or activate the comple-
ment system [48]. In AvIDP there is a considerable
body of evidence for employment of both pathways.
Immunohistological, flow cytometrical and gene expres-
sion studies confirm the presence of significant numbers
of ab T-cells of both T-helper and cytotoxic T-cell
(CTL) phenotypes. Gene expression profiling further
indicated a dominance of a Th1-like immune response
as demonstrated by a significant upregulation of IFNg
mRNA and no changes in IL-13 mRNA levels in
affected nerves in comparison to healthy controls
[49,50]. Th1-like immune responses have been described
as taking part in acute EAN and in the initial stages of
AIDP; findings which further underline the similarity
between AIDP and AvIDP [51,52].
On the other hand, one may ask if the high density of
endoneurial plasma cells and deposition of myelin-
bound IgG lend credence to a simultaneous recruitment
of humoral effector mechanisms [53]. IL-10 expression
suggests a Th-cell-dependency rather than a primary
humoral response [54]. Morphological examination sug-
gests, and quantitative PCR confirms, that humoral
pathways seem to predominate at the stage of AvIDP
disease investigated in this study. B-cell and plasma cell
activation is reflected by high mRNA expression levels
of chB6 (Bu-1) and B lymphocyte-induced maturation
protein-1 (Blimp-1) in the affected spinal ganglia
[38,55]. Interestingly, IL-13 was - despite the indications
for a predominantly humoral pathway - not significantly
elevated [56,57], which may be explained by the stage of
disease (see below).
The increase in mRNA expression of IL-10 is sugges-
tive of down-regulation of the immune response
[54,58,59] and it is in line with the observation of a
remission of the clinical deficits soon after the paraly-
tic phase in an additional group of animals subjected
to long-term trials (unpublished data; see below).
Furthermore, there was no elevation of IL-1 and IL-
6, which contrasts with common observations of an
acute inflammatory reaction [60,61]. Even though there
is an increase in IFNg-level, it seems not to have led to
the transformation of macrophages into inflammatory
macrophages that would have produced higher levels
of iNOS in addition to IL-1 and IL-6 [62,63].
In accord with recent data on AIDP and on rodent
GBS models [9], it may be concluded that the parapare-
t i cb i r d si nt h i ss t u d yw e r ej u s ta b o u tt ol e a v eaT h 1 -
driven initial stage for a Th2-dominated plateau or even
Figure 8 Ongoing demyelination/remyelination. A: Demyelination is accompanied by proliferation of Schwann cells (SC), formation of
supernumerary processes, and a significant expansion of the collagenous inner endoneurial sheath. Schwann cells show no sign of
degeneration. B: Inappropriately thin myelin sheaths and redundant Schwann cells are consistent with ongoing remyelination. Apart from
macrophages, the endoneurium of affected nerves shows significant infiltration by plasma cells and lymphocytes (LC). A: FB = fibroblast; Scale
bars = 1 μm (A), 250 nm (B).
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Page 13 of 20recovery phase. It is very likely that the occurrence of
neurological deficits coincides with late a Th1-stage or a
Th1-to-Th2-transition, which implies the existence of a
considerable preclinical period in disease progression.
Because of the spontaneous appearance of disease, and
the low incidence (1 per 100 animals) at earlier stages of
AvIDP would be very difficult to assess through random
sampling in preparetic chickens.
Concerning the natural history of the disease, how-
ever, we have launched preliminary longitudinal trials
in order to clarify whether AvIDP resembles an acute
monophasic disease or a chronic progressive, stagnant
or even remitting-relapsing disease with sudden onset.
Our preliminary observations indicate that remission
and relapse of clinical signs is possible.
In GBS and CIDP, several auto-antibodies have been
demonstrated to react with myelin proteins and per-
ipheral nerve gangliosides. Auto-antibodies against
myelin proteins P0, P2 and PMP-22 [64] are associated
with AIDP and CIDP in humans. These proteins are
uniformly distributed throughout the PNS and do not
explain either the proximodistal gradient of inflamma-
tory demyelination or the variations in degree of invol-
vement amongst different nerves. Ganglioside
composition, however, does vary among different cra-
nial nerves [65]. It therefore has been shown in AIDP
and CIDP in humans, and in corresponding animal
models in laboratory animals, that the profile of anti-
ganglioside antibodies may predict the clinical pheno-
type [66,67]. Hence, oculomotor nerve involvement is
a characteristic feature of the Miller-Fisher syndrome
and of GBS with ophthalmoplegia associated with anti-
bodies directed against the ganglioside GQ1b that is
particularly abundant in CNIII [65,68]. The binding
partners for IgG in AvIDP remain to be identified but
the remarkable involvement of CNIII and CNV render
similarly distributed avian gangliosides likely target
molecules for immunoaggression, even though Miller-
Fisher syndrome and GBS with ophthalmoplegia are
axonal diseases [48,69].
In analogy to EAN models, the main fraction of
recruited T-cells carried ab T-cell receptors [70]. Even
though a contribution of gδ T-cells to human IDP has
been documented, indicating a role of non-peptide
antigens as triggers for autoaggression [71,72], the pre-
valence of at least 10% gδ T - c e l l si nA v I D Ph a st ob e
interpreted with caution since this T-cell population
represents about 20 to 50% of the circulating T-cell
pool in chickens under physiological conditions [73].
In contrast, humans gδ T-cells represent approximately
1 to 15% of peripheral blood lymphocytes [74].
So far, the aetiology of AvIDP is still undetermined.
Preceding events associated with the onset of GBS range
from viral, mycoplasmal and bacterial infections to sur-
gery, vaccination, fever treatment and other stressful
conditions [75,76]. All chickens, affected and unaffected,
originated from one single flock and were raised in an
identical environment regarding diet, housing and expo-
sure to environmental pathogens. In contrast to SPF-
animals, these chickens are exposed to permanent infec-
tion pressures that remain to be controlled by tight
polyvaccination management.
Thus, an association with preceding infection, as well
as with vaccination, may be involved in disease develop-
ment via molecular mimicry as has been documented in
GBS [76,77].
Figure 9 Immunohistochemical evidence of infiltration by T-
cells (CD3
+), B-cells (chB6
+) and macrophages (Kul01
+).
Immunophenotyping identified the majority of infiltrating
lymphocytes as being CD3-positive T-cells (A). They show a
characteristic multifocal distribution pattern. With similar spatial
characteristics, chB6-positive B-cells comprise the second largest
fraction of infiltrating cells (B). Compared to the lymphocytes, the
density of Kul01-positive macrophages appears much lower (C). The
arrows point to immunopositive cells. All sections were prepared
from the same region of the sciatic nerve. The orientation of the
nerve fibres (NF) is indicated. Scale bar = 35 μm.
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tions in chicken flocks are generally limited by strict
vaccination programs and by routine health monitor-
ing. However, worldwide distribution, paired with neu-
rotropism and some overlapping clinical and
histopathological features, render Marek’sd i s e a s eh e r -
pesvirus an important candidate amongst avian infec-
tious agents [78]. Previous studies already have
emphasised the similarity of demyelination in Marek’s
disease (MD) and in EAN [79-81]. Moreover, GBS has
been associated with a panel of human herpesviruses,
namely Varicella-zoster virus [82-84], cytomegalovirus
[84-86], Herpes simplex virus [84] and more frequently
Epstein Barr virus [84-86]. We therefore employed a
PCR protocol that allows for the discrimination of
MDV vaccine and field strains. The results of this PCR
analysis strongly suggest that infections with virulent
MDV strains should not be considered as the cause of
AIDP.
In addition to preceding infections, vaccinations have
been reported risk factors for GBS and CIDP in
humans. Anteceding immunizations with vaccines
against influenza, hepatitis, measles, mumps, and
rubella and others infrequently have been associated
with GBS [77,87-89]. All chickens in this study were
vaccinated in the first few weeks post hatching with
inactivated or live vaccines against MDV, Newcastle
disease virus, infectious bursal disease virus, avian
infectious bronchitis virus, Salmonella spp., and cocci-
diosis. Hence, multivaccination appears a possible
immunological trigger. The potential contribution of
infections and/or immunizations to disease develop-
ment is supported by the observation that SPF animals
of the same genetic background do not develop
Figure 10 Deposition of IgG within the myelin sheath of affected fibres. Longitudinal (A) and cross (C) sections of unaffected samples
show immunonegative nerve fibres (NF) throughout (empty arrow), whereas inflamed specimens reveal a significant intramyelinic IgG-deposition
(B, D; black arrows) in many fibres within (B) or even outside (D) of significantly infiltrated foci. The longitudinal orientation of the nerve fibers is
indicated by the double-headed arrow (A). Scale bars = 10 μm (A, B), 15 μm (C, D).
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Page 15 of 20Figure 11 Leukocytes in spinal ganglia from diseased birds consist of different subpopulations. For flow cytometric analysis, single cell
suspensions from spinal ganglia of diseased birds were stained with a Pan-Leukocyte marker (CD45) and antibodies for T cells (CD3), cytotoxic T
cells (CD8), T helper cells (CD4), T cell receptor types TCR1, TCR2 and TCR3 (TCRgδ, TCRa/vb1, TCRa/vb2), B cells (AV20), macrophages (Kul01)
and MHC class II (2G11). (A) Gating was first performed on cells with leukocyte scatter characteristics, secondly on CD45+ cells before the
proportion of different lymphocyte subpopulations of all CD45+ leukocytes was determined. (B) Data expressed as mean ± SD for different
subpopulations for five birds analysed.
Figure 12 Relative Gene expression in spinal ganglia of chicken. The mRNA abundance of candidate genes using quantitative RT-PCR was
analysed in ganglia of affected and non-affected chickens of the same age, originated from the same flock. Gene expression, measured using
SYBR Green primer assays and Ct values, were normalised against 18S rRNA (= dCT). Data shown as mean ± SD for 40-dCT values for eight
animals per group (** p ≤ 0.01; * p ≤ 0.05).
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chickens are mandatory to evaluate the possible role of
vaccination programs for AvIDP development.
While external triggers still remain uncertain, we were
able to identify a genetic susceptibility factor confined
to the avian major histocompatibility complex (MHC),
the so called B-complex. The four genotypes studied
displayed marked differences in risk of being affected by
AvIDP. Most obvious was the increased risk of genotype
[261/539] compared to others. In addition, genotype
[357/539] also showed higher risk of AvIDP compared
to genotype [261/357], and, to a lesser extend, compared
to genotype [261/261] as well.
Moreover, the percentage of AvIDP-affected animals
was significantly higher for genotypes [261/539] and
[357/539] than for the other two haplotype combina-
tions. Results suggest an association of marker LEI0258,
located in the MHC region of the chicken, with the
occurrence of AvIDP as earlier indicated by Bacon et al.
[16]. Thereby, the allele with a fragment size of 539 bp
seems to be linked to an elevated risk of developing this
disease.
Likewise, in the highly susceptible Lewis rats that are
commonly used in EAN trials, a certain allele of a
MHC-linked gene - amongst further, non-MHC
regions - is necessary in the MHC or RT1 region to
confer EAE susceptibility in the F2 progeny [90].
Furthermore, HLA-DR2 is associated with a higher
susceptibility to CIDP in humans [91]. In GBS, a
genetic background is also suspected but has not yet
been confirmed [92,93].
To date, EAN is the most frequently used animal
model for investigation of immunopathological
mechanisms in acute inflammatory demyelinating dis-
eases of the PNS [13]. Even though it strongly resem-
bles AIDP histopathologically, there are several
disadvantages and dissimilarities to the human disease
in terms of CNS involvement - which is very rare in
GBS [20,94] - and a monocausal neuritogenic trigger,
that poorly reflects the natural disease development
[13].
Like AIDP and EAN, AvIDP is characterised by infil-
tration of nerve roots and peripheral nerves with macro-
phages and lymphocytes and, most importantly, a cell-
mediated demyelination [13,95]. In AvIDP the CNS is
not involved at any time, as is described for the vast
majority of GBS cases [20,94].
Compared to experimental immunization with
mimicked epitopes, the spontaneous disease develop-
ment of AvIDP is much closer to the field situation and
provides an opportunity to investigate aetiological fac-
tors through purposed-based exposure and manipula-
tions of the environment.
A drawback of AvIDP as a disease model lays in the
difficulty to identify pre- or subclinical animals and
thereby the very early stages of immunopathology,
before switching from Th1- to Th2-mediated cascades.
However, scientific approaches to AvIDP are facilitated
by its availability, reproducibility and economic consid-
erations. In a flock of up to 5000 animals, a mean
number of 50 to 200 chickens is affected per 18 weeks
of the breeding cycle. In addition, the availability of
the chicken genome sequence now greatly facilitates
genetic and immunological studies and has lead to the
availability of numerous molecular tools for detailed
studies [96]. This and the possibility to select suscepti-
ble and resistant birds make the AvIDP-chicken a valu-
able model system for further studies of inflammatory
demyelinating polyradiculoneuropathies.
Conclusions
Sporadic paralysis in juvenile White Leghorn chickens is
caused by an inflammatory demyelination of cranial and
Table 3 Allele frequency in healthy and clinically AvIDP-diseased animals
Genotype
[261/261] [261/539] [357/539] [261/357]
Healthy 15 (83.3) 53 (35.3) 7 (58.3) 77 (90.6)
Diseased 3 (16.7) 97 (64.7) 5 (41.7) 8 (9.4)
Total 18 150 12 85
Figure 13 Fragment length polymorphism of LEI0258. Blood
group genotyping revealed an association between AvIDP and
MHC haplotype with a fragment size of 539 bp. The individual with
genotype [261/357] was healthy.
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Page 17 of 20peripheral nerves. Paralytic stages are associated with
humoral immune events that resemble the late stage of
AIDP in humans. The natural development of AvIDP is
an advantage over EAN regarding research on disease
causing factors. MHC-related genetic factors are
involved in disease susceptibility. Taken together, AvIDP
may serve as a valuable model for further investigations
on the aetiology and immunobiology of AIDP as well as
its therapy.
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